Tag hrpc [27 articles] Export

Recent papers classified by the tag hrpc.

	Immediate Hormonal Therapy Compared with Observation after Radical Prostatectomy and Pelvic Lymphadenectomy in Men with Node-Positive Prostate Cancer [My Copy] N Engl J Med, Vol. 341, No. 24. (9 December 1999), pp. 1781-1788. by Edward M. Messing, Judith Manola, Michael Sarosdy, George Wilding, David E. Crawford, Donald Trump posted to cancer delayed hormone hrpc prostate survival by prost8 on 2009-05-27 13:31:48 as
	Hydrocortisone With or Without Mitoxantrone in Men With Hormone-Refractory Prostate Cancer: Results of the Cancer and Leukemia Group B 9182 Study [My Copy] J Clin Oncol, Vol. 17, No. 8. (1 August 1999), 2506. by Philip W. Kantoff, Susan Halabi, Mark Conaway, et al.Joel Picus, Jeffrey Kirshner, Vera Hars, Donald Trump, Eric P. Winer, Nicholas J. Vogelzang posted to cancer hormone hrpc mitoxantrone prostate survival by prost8 on 2009-05-27 12:57:16 as
	Chemotherapy with mitoxantrone plus prednisone or prednisone alone for symptomatic hormone-resistant prostate cancer: a Canadian randomized trial with palliative end points [My Copy] J Clin Oncol, Vol. 14, No. 6. (1 June 1996), pp. 1756-1764. by I. F. Tannock, D. Osoba, M. R. Stockler, et al.D. S. Ernst, A. J. Neville, M. J. Moore, G. R. Armitage, J. J. Wilson, P. M. Venner, C. M. Coppin, K. C. Murphy posted to cancer hormone hrpc mitoxantrone prostate survival by prost8 on 2009-05-27 12:54:49 as
	Studies with CWR22 Xenografts in Nude Mice Suggest That ZD1839 May Have a Role in the Treatment of Both Androgen-dependent and Androgen-independent Human Prostate Cancer [My Copy] Clin Cancer Res, Vol. 8, No. 12. (1 December 2002), pp. 3870-3876. by Francis M. Sirotnak, Yohung She, Fei Lee, Jing Chen, Howard I. Scher posted to cite egfr fulltext hrpc therapy by zkyken on 2007-06-13 15:54:43 as
	Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer. [My Copy] N Engl J Med, Vol. 351, No. 15. (7 October 2004), pp. 1502-1512. by I. F. Tannock, R. de Wit, W. R. Berry, et al.J. Horti, A. Pluzanska, K. N. Chi, S. Oudard, C. Théodore, N. D. James, I. Turesson, M. A. Rosenthal, M. A. Eisenberger, posted to cancer cite fulltext hrpc prostate by zkyken on 2007-06-13 15:16:36 as along with 2 people OncReadingGroup zebkhan
	Cancer progression and survival rates following anatomical radical retropubic prostatectomy in 3,478 consecutive patients: long-term results. [My Copy] J Urol, Vol. 172, No. 3. (September 2004), pp. 910-914. by K. A. Roehl, M. Han, C. G. Ramos, J. A. Antenor, W. J. Catalona posted to cancer cite hrpc surgery by zkyken on 2007-06-13 15:12:29 as
	Natural history of progression after PSA elevation following radical prostatectomy. [My Copy] JAMA, Vol. 281, No. 17. (5 May 1999), pp. 1591-1597. by C. R. Pound, A. W. Partin, M. A. Eisenberger, D. W. Chan, J. D. Pearson, P. C. Walsh posted to cancer cite hrpc prostate by zkyken on 2007-06-13 15:10:27 as along with 1 person xingxu
	The management of hormone refractory prostate cancer. [My Copy] Eur Urol, Vol. 29 Suppl 2 (1996), pp. 69-74. by D. W. Newling posted to cancer cite hrpc prostate by zkyken on 2007-06-13 15:03:39 as
	Cancer statistics, 1993. [My Copy] CA Cancer J Clin, Vol. 43, No. 1. (b 1993), pp. 7-26. by C. C. Boring, T. S. Squires, T. Tong posted to cancer hrpc prostate by zkyken on 2007-06-13 15:01:36 as
	Screening and identification of differentially expressed transcripts in circulating cells of prostate cancer patients using suppression subtractive hybridization. [My Copy] Mol Cancer, Vol. 4, No. 1. (2005) by X. Li, C. Wong, R. Mysel, et al.G. Slobodov, A. Metwalli, J. Kruska, C. S. Manatt, D. J. Culkin, B. P. Kropp, H. K. Lin posted to hrpc ssh by zkyken on 2007-06-05 04:33:16 as
	A high throughput screening for rarely transcribed differentially expressed genes [My Copy] Nucl. Acids Res., Vol. 25, No. 13. (1 July 1997), pp. 2598-2602. by Od von Stein, Wg Thies, M. Hofmann posted to hrpc ssh by zkyken on 2007-06-05 04:28:06 as
	Differentially Expressed Genes in Hormone Refractory Prostate Cancer : Association with Chromosomal Regions Involved with Genetic Aberrations [My Copy] Am J Pathol, Vol. 154, No. 5. (1 May 1999), pp. 1335-1343. by Andrew P. Stubbs, Paul D. Abel, Matthew Golding, et al.Gurjeet Bhangal, Qin Wang, Jonathan Waxman, Gordon W. Stamp, El-Nasir Lalani posted to hrpc by zkyken on 2007-06-05 04:23:41 as
	Detection of differentially expressed genes in prostate cancer by combining suppression subtractive hybridization and cDNA library array [My Copy] The Journal of Pathology, Vol. 193, No. 1. (2001), pp. 73-79. by Kati P. Porkka, Tapio Visakorpi posted to hrpc by zkyken on 2007-06-05 04:21:00 as
	Current Drug Therapy for Prostate Cancer: An Overview [My Copy] Current Medicinal Chemistry - Anti-Cancer Agents, Vol. 5, No. 6. (November 2005), pp. 603-612. by A. B. Stewart, B. A. Lwaleed, D. A. Douglas, B. R. Birch posted to hrpc by zkyken on 2007-06-05 04:09:52 as
	Hormone Resistance in Prostate Cancer [My Copy] Cancer and Metastasis Reviews, Vol. 17, No. 4. (1 December 1998), pp. 373-381. by Mary J. Pilat, Jeffery M. Kamradt, Kenneth J. Pienta posted to hrpc by zkyken on 2007-06-05 04:07:35 as
	$My PDF carducci_05_hormonerefractory.pdf$ Hormone-refractory prostate cancer: Issues, approaches, and recommendations [My Copy] Urology In Moving Beyond Hormone-Refractory Prostate Cancer, Vol. 65, No. 5, Supplement 1. (May 2005), pp. 1-2. by Michael A. Carducci, Peter R. Carroll, Robert S. Dipaola, et al.Joel B. Nelson, Daniel P. Petrylak, Mathew R. Smith, Ian M. Thompson posted to hrpc by zkyken on 2007-06-05 04:05:54 as
	Mechanisms of the development of androgen independence in prostate cancer [My Copy] World Journal of Urology, Vol. 23, No. 1. (1 February 2005), pp. 1-9. by Alan So, Martin Gleave, Antonio Hurtado-Col, Colleen Nelson posted to hrpc by zkyken on 2007-06-05 04:04:03 as
	$My PDF de la taille_01_hormonerefractory.pdf$ Hormone-refractory prostate cancer: a multi-step and multi-event process. [My Copy] Prostate Cancer Prostatic Dis, Vol. 4, No. 4. (2001), pp. 204-212. by A De La Taille, F Vacherot, L Salomon, et al.C Druel, S Gil Diez De Medina, C Abbou, R Buttyan, D Chopin posted to hrpc by zkyken on 2007-06-05 03:40:06 as
	Achieving treatment goals for hormone-refractory prostate cancer with chemotherapy. [My Copy] Oncologist, Vol. 10 Suppl 3 (2005), pp. 30-39. by W. Berry, M. Eisenberger posted to hrpc by zkyken on 2007-06-05 03:39:06 as
	A retrospective analysis of the relationship between changes in serum PSA, palliative response and survival following systemic treatment in a Canadian randomized trial for symptomatic hormone-refractory prostate cancer. [My Copy] Ann Oncol, Vol. 12, No. 6. (June 2001), pp. 773-778. by A. J. Dowling, T. Panzarella, D. S. Ernst, A. J. Neville, M. J. Moore, I. F. Tannock posted to hrpc by zkyken on 2007-06-05 03:37:52 as
	State-of-the-art treatment of metastatic hormone-refractory prostate cancer. [My Copy] Oncologist, Vol. 7, No. 4. (2002), pp. 360-370. by S. Goodin, K. V. Rao, R. S. DiPaola posted to hrpc by zkyken on 2007-06-05 03:33:06 as
	$My PDF rini_02_hormonerefractory.pdf$ Hormone-refractory Prostate Cancer. [My Copy] Curr Treat Options Oncol, Vol. 3, No. 5. (October 2002), pp. 437-446. by B. I. Rini, E. J. Small posted to hrpc by zkyken on 2007-06-05 03:31:06 as
	The treatment challenge of hormone-refractory prostate cancer. [My Copy] Cancer Control, Vol. 8, No. 6. (c 2001), pp. 487-495. by J. A. Kish, R. Bukkapatnam, F. Palazzo posted to hrpc by zkyken on 2007-06-05 03:29:17 as
	Management of patients with hormone refractory prostate cancer. [My Copy] Clin Oncol (R Coll Radiol), Vol. 16, No. 8. (December 2004), pp. 505-516. by S. R. Muthuramalingam, K. Patel, A. Protheroe posted to hrpc by zkyken on 2007-06-05 03:26:14 as along with 1 person pkufranky
	New standards in the chemotherapy of metastatic hormone-refractory prostate cancer. [My Copy] Expert Rev Anticancer Ther, Vol. 5, No. 1. (February 2005), pp. 53-62. by T. Sava, U. Basso, A. Porcaro, G. L. Cetto posted to hrpc by zkyken on 2007-06-05 03:24:00 as
	Identification of genes linked to gefitinib treatment in prostate cancer cell lines with or without resistance to androgen: a clue to application of gefitinib to hormone-resistant prostate cancer. [My Copy] Oncol Rep, Vol. 15, No. 6. (June 2006), pp. 1453-1460. by S. Yano, H. Matsuyama, H. Hirata, et al.R. Inoue, H. Matsumoto, C. Ohmi, K. Miura, M. Shirai, N. Iizuka, K. Naito posted to cite egfr fulltext hrpc by zkyken on 2007-05-13 09:03:21 as
	Absence of epidermal growth factor receptor gene mutations in patients with hormone refractory prostate cancer not responding to gefitinib. [My Copy] Prostate, Vol. 67, No. 6. (1 May 2007), pp. 603-604. by G. Curigliano, G. Pelosi, T. De Pas, et al.G. Renne, O. De Cobelli, M. Manzotti, G. Spitaleri, F. de Braud posted to cite egfr hrpc by zkyken on 2007-05-07 15:22:38 as along with 1 person and 1 group cursonivel1 cursonivel1